ADC Therapeutics SA SEC filings ADCT
ADC Therapeutics SA has 438 filings in SEC EDGAR's recent list, going back to Jun 27, 2019. Its latest annual report, Form ARS, was filed on Mar 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-4 | Registration for a merger or exchange | Nov 3, 2026 | — |
| S-8 | Employee stock plan registration | Aug 13, 2026 | — |
| 424B3 | Prospectus | Apr 15, 2026 | — |
| 424B3 | Prospectus | Mar 16, 2026 | — |
| S-3 | Shelf registration | Mar 10, 2026 | — |
| 424B3 | Prospectus | Dec 12, 2025 | — |
| S-3/A | Form s-3/a | Dec 9, 2025 | — |
| S-3 | Shelf registration | Nov 10, 2025 | — |
| S-8 | Employee stock plan registration | Sep 30, 2025 | — |
| S-8 | Employee stock plan registration | Aug 12, 2025 | — |
| 424B3 | Prospectus | Jul 10, 2025 | — |
| S-3 | Shelf registration | Jun 30, 2025 | — |
| S-3 | Shelf registration | Aug 6, 2024 | — |
| 424B5 | Prospectus supplement | May 7, 2024 | — |
| 424B5 | Prospectus supplement | May 6, 2024 | — |
| 424B3 | Prospectus | Mar 15, 2024 | — |
| 424B3 | Prospectus | Mar 15, 2024 | — |
| POS AM | Form pos am | Mar 13, 2024 | — |
| POS AM | Form pos am | Mar 13, 2024 | — |
| POS AM | Form pos am | Mar 13, 2024 | — |
| S-8 | Employee stock plan registration | Dec 18, 2023 | — |
| S-8 | Employee stock plan registration | Dec 4, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 15, 2023 | — |
| S-8 | Employee stock plan registration | Mar 15, 2023 | — |
| 424B7 | Form 424b7 | Feb 2, 2023 | — |
| FWP | Free writing prospectus | Feb 2, 2023 | — |
| FWP | Free writing prospectus | Feb 2, 2023 | — |
| 424B3 | Prospectus | Sep 16, 2022 | — |
| 424B3 | Prospectus | Sep 16, 2022 | — |
| F-3 | Shelf registration (foreign issuer) | Sep 6, 2022 | — |
| F-3 | Shelf registration (foreign issuer) | Sep 6, 2022 | — |
| POS AM | Form pos am | Aug 16, 2022 | — |
| S-8 | Employee stock plan registration | Jun 30, 2022 | — |
| F-3ASR | Form f-3asr | Jun 4, 2021 | — |
| F-3ASR | Form f-3asr | Jun 1, 2021 | — |
| S-8 | Employee stock plan registration | May 6, 2021 | — |
| 424B4 | Prospectus | Sep 25, 2020 | — |
| F-1 | Registration statement (foreign issuer) | Sep 21, 2020 | — |
| 424B4 | Prospectus | May 18, 2020 | — |
| S-8 | Employee stock plan registration | May 15, 2020 | — |
| F-1MEF | Filing | May 14, 2020 | — |
| F-1/A | Filing | May 14, 2020 | — |
| F-1/A | F1a | May 11, 2020 | — |
| F-1/A | Filing | Apr 27, 2020 | — |
| F-1 | Registration statement (foreign issuer) | Apr 24, 2020 | — |
| F-1/A | Filing | Sep 23, 2019 | — |
| F-1 | Registration statement (foreign issuer) | Sep 6, 2019 | — |
Showing 47 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ADCT (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Switzerland
- Headquarters
- Epalinges, Switzerland
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1771910
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.